NHS England offers to fund doubling of PrEP trial NHS England has said it will fund the doubling of the size of its trial of the HIV prevention drug PrEP to provide an additional 13,000 patients with the drug.…
London to end minor ailments service with replacement solely for ‘vulnerable’ patients Exclusive: A community pharmacy-run minor ailments service exclusively for people who are “socially vulnerable” is being planned for London.…
NHS ten-year plan: good for pharmacists, but what about pharmacies? Although the ‘NHS Long-Term Plan’ outlines some potential new roles for pharmacists, the lack of detail on plans for community pharmacy are cause for concern.…
NHS England to pilot patient referral scheme between GPs and community pharmacy NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed.…
NHS long-term plan ‘fantastic’ for pharmacy but will require ‘transformative change’ Pharmacy leaders have warned that the community pharmacy sector will have to change significantly if recommendations for pharmacy made in the 10-year plan for the NHS in England are to be implemented successfully.…
Cost of medicines in hospitals increased by 11% in 2017/2018 The cost of medicines prescribed in hospitals has increased by nearly 11% over the past year, according to official NHS data.…
Patients diagnosed with type 2 diabetes to be put on 800-calorie diet in new NHS pilot People diagnosed with type 2 diabetes will be placed on a new low-calorie diet as part of a pilot scheme to treat the condition, NHS England has announced.…
NHS England looks to save £70m by curbing prescribing of eight more items in primary care NHS England has launched a public consultation on whether to limit the prescribing of eight items in an effort to save almost £70m per year.…
Two new flu vaccines may be licensed for use before next winter, says NHS England Pharmacists may have two further options when vaccinating patients aged over 65 years against flu in 2019/2020, NHS England has advised.…
NHS England to save £300m after patent expiry of most costly drug The NHS in England will save £300m from the patent expiry of adalimumab, the most costly drug used in NHS hospitals, which is double previous estimates, NHS England has announced.…
